148 related articles for article (PubMed ID: 2465438)
1. Adaptational process of the cardiac Ca2+ channels to pressure overload: biochemical and physiological properties of the dihydropyridine receptors in normal and hypertrophied rat hearts.
Mayoux E; Callens F; Swynghedauw B; Charlemagne D
J Cardiovasc Pharmacol; 1988 Oct; 12(4):390-6. PubMed ID: 2465438
[TBL] [Abstract][Full Text] [Related]
2. Effect of pressure overload on cardiac Ca2+ antagonist binding sites of guinea pig. Comparison with the adaptational response of the hypertrophied rat heart.
Primot I; Mayoux E; Oliviero P; Charlemagne D
Cardiovasc Res; 1991 Oct; 25(10):875-80. PubMed ID: 1660790
[TBL] [Abstract][Full Text] [Related]
3. Sarcolemmal Ca2+ transport activities in cardiac hypertrophy caused by pressure overload.
Nakanishi H; Makino N; Hata T; Matsui H; Yano K; Yanaga T
Am J Physiol; 1989 Aug; 257(2 Pt 2):H349-56. PubMed ID: 2548404
[TBL] [Abstract][Full Text] [Related]
4. Nitrendipine binding in congestive heart failure due to myocardial infarction.
Dixon IM; Lee SL; Dhalla NS
Circ Res; 1990 Mar; 66(3):782-8. PubMed ID: 2155068
[TBL] [Abstract][Full Text] [Related]
5. High affinity specific [3H](+)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart.
Lee HR; Roeske WR; Yamamura HI
Life Sci; 1984 Aug; 35(7):721-32. PubMed ID: 6088927
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of receptor sites for [3H]nitrendipine in chick hearts and physiological relation to the slow Ca2+ channel and to excitation-contraction coupling.
Renaud JF; Kazazoglou T; Schmid A; Romey G; Lazdunski M
Eur J Biochem; 1984 Mar; 139(3):673-81. PubMed ID: 6321185
[TBL] [Abstract][Full Text] [Related]
7. Effect of inorganic calcium channel blockers on dihydropyridine binding to cardiac sarcolemma.
Schilling WP; Zaher MC; Rampe D
Mol Pharmacol; 1990 Jan; 37(1):80-9. PubMed ID: 2137194
[TBL] [Abstract][Full Text] [Related]
8. Regulation of cardiac sarcolemmal Ca2+ channels and Ca2+ transporters by thyroid hormone.
Seppet EK; Kolar F; Dixon IM; Hata T; Dhalla NS
Mol Cell Biochem; 1993 Dec; 129(2):145-59. PubMed ID: 8177237
[TBL] [Abstract][Full Text] [Related]
9. Calcium ions inhibit the allosteric interaction between the dihydropyridine and phenylalkylamine binding site on the voltage-gated calcium channel in heart sarcolemma but not in skeletal muscle transverse tubules.
Murphy BJ; Tuana BS
Can J Physiol Pharmacol; 1990 Nov; 68(11):1389-95. PubMed ID: 1962734
[TBL] [Abstract][Full Text] [Related]
10. Calcium antagonist binding sites in failing and nonfailing human ventricular myocardium.
Rasmussen RP; Minobe W; Bristow MR
Biochem Pharmacol; 1990 Feb; 39(4):691-6. PubMed ID: 2154992
[TBL] [Abstract][Full Text] [Related]
11. Normal responsiveness to external Ca and to Ca-channel modifying agents in hypertrophied rat heart.
Callens-el Amrani F; Mayoux E; Mouas C; Clapier-Ventura R; Henzel D; Charlemagne D; Swynghedauw B
Am J Physiol; 1990 Jun; 258(6 Pt 2):H1727-34. PubMed ID: 1694410
[TBL] [Abstract][Full Text] [Related]
12. An effect of ischemia on myocardial dihydropyridine binding sites.
Nayler WG; Dillon JS; Elz JS; McKelvie M
Eur J Pharmacol; 1985 Sep; 115(1):81-9. PubMed ID: 2412860
[TBL] [Abstract][Full Text] [Related]
13. Altered Ca2+ dynamics in single cardiac myocytes from renovascular hypertensive rats.
Moore RL; Yelamarty RV; Misawa H; Scaduto RC; Pawlush DG; Elensky M; Cheung JY
Am J Physiol; 1991 Feb; 260(2 Pt 1):C327-37. PubMed ID: 1825451
[TBL] [Abstract][Full Text] [Related]
14. Characterization of calcium antagonist receptors in highly purified porcine cardiac sarcolemma.
Haase H; Wallukat G; Vetter R; Will H
Biomed Biochim Acta; 1987; 46(8-9):S363-9. PubMed ID: 2829862
[TBL] [Abstract][Full Text] [Related]
15. Thermodynamic and kinetic aspects of agonist and antagonist binding to 1,4-dihydropyridine receptors.
Zheng W; Hawthorn M; Triggle DJ
Eur J Pharmacol; 1991 Oct; 208(2):137-47. PubMed ID: 1724760
[TBL] [Abstract][Full Text] [Related]
16. Effect of propionyl-L-carnitine on L-type calcium channels in human heart sarcolemma.
Bevilacqua M; Vago T; Norbiato G
Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():31-5. PubMed ID: 1851633
[TBL] [Abstract][Full Text] [Related]
17. Characterization of 1,4, dihydropyridine calcium channel binding sites in the human prostate.
Rosenthal E; Shapiro E; Lepor H
J Urol; 1990 Dec; 144(6):1539-42. PubMed ID: 1700163
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the binding of [3H]SR 33805 to the slow Ca2+ channel in rat heart sarcolemmal membrane.
Chatelain P; Dewinkeleer P; Beaufort P; Meysmans L; Clinet M
Eur J Pharmacol; 1994 Apr; 267(2):151-60. PubMed ID: 8050476
[TBL] [Abstract][Full Text] [Related]
19. Increased [3H]nitrendipine binding sites in rat heart during adult maturation and aging.
Navaratnam S; Khatter JC
Biochem Pharmacol; 1991 Feb; 41(4):593-600. PubMed ID: 1847636
[TBL] [Abstract][Full Text] [Related]
20. Interactions of cryptosin with mammalian cardiac dihydropyridine-specific calcium channels.
Rao VR; Banning JW
Life Sci; 1990; 47(18):1667-76. PubMed ID: 2174493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
